NovelSOX17frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutations

Authors:

Abstract
Novel SOX17 frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutations Novel SOX17 frameshift mutations in endometrial cancer are functionally distinct from recurrent missense mutations

This publication has 50 references indexed in Scilit: